Recombinant antibody production utilizes Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex biologics. Improving these processes involves fine-tuning various factors, including cell line selection, media composition, and bioreactor environments. A key goal is to maximize antibody production while minimizing production c